Neutrophils in triple-negative breast cancer: an underestimated player with increasingly recognized importanceChanjuan Zheng, Xiyun Deng, Guangchun He et al.|Breast Cancer Research|2023Cited by 53
Unlocking the Hidden Potential of Cancer Therapy Targeting Lysine SuccinylationZhuomeng Zheng, Xiyun Deng, Peiyao Xiao et al.|Journal of Cancer|2024Cited by 8
Dysregulated Ribosome Biogenesis Is a Targetable Vulnerability in Triple-Negative Breast Cancer: MRPS27 as a Key Mediator of the Stemness-inhibitory Effect of LovastatinChanjuan Zheng, Xiyun Deng, Hui Yao et al.|International Journal of Biological Sciences|2024Cited by 7
Amino acids and their roles in tumor immunotherapy of breast cancerHongzhuo Xia, Xiyun Deng, Jianyu Zhu et al.|The Journal of Gene Medicine|2023Cited by 2
Lovastatin Targets the USP14–Survivin Axis to Suppress Triple-Negative Breast Cancer via Ubiquitin-Mediated Proteasomal DegradationLi Zhou, Xiyun Deng, Chanjuan Zheng et al.|Cells|2025Cited by 2